Operating Responsibly

Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we collect are used safely, ethically, and responsibly.

Videos from this campaign

Content from this campaign

Awards, Ratings & Rankings

Illumina Ranks 5th Overall in TIME’s World’s Most Sustainable Companies 2024 List
Illumina ranks 5th overall and is the top-ranking company in the U.S. and the biotechnology industry in TIME’s ‘World's Most Sustainable Companies 2024’ list. The list ranks the top 500 companies out of more than 3,000 reviewed.

Research, Reports & Publications

Illumina Releases 2023 Corporate Social Responsibility Report
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report.

Awards, Ratings & Rankings

Illumina Named One of America’s Most JUST Companies and Included in the 2024 S&P Global Sustainability Yearbook
For the fifth year in a row, Illumina has been named one of America’s Most JUST Companies by JUST Capital and CNBC. Illumina ranked #29, out of the top 100, and second in the pharmaceutical and biotech industry.

Awards, Ratings & Rankings

Illumina Named to the Dow Jones Sustainability Indices for the Fifth Consecutive Year
Illumina has been named to the Dow Jones Sustainability World Index and the North America Index for 2023 in the Life Sciences Tools & Services Industry. This is the fifth consecutive year the company has been named to the prestigious list.

Awards, Ratings & Rankings

Illumina Included on 2023 List of 100 Best Corporate Citizens List
Illumina has been included on the 2023 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest U.S. public companies.

Awards, Ratings & Rankings

Illumina Receives Highest Distinction in the 2023 S&P Global Sustainability Yearbook
Illumina has been included in the 2023 S&P Global Sustainability Yearbook for the fourth consecutive year. This year, Illumina’s S&P Global ESG Score is in the top 1% and is the top-performing company in the Life Sciences Tools & Services industry.

Awards, Ratings & Rankings

Illumina Selected as One of America’s Most JUST Companies
Illumina has been named one of America’s Most JUST Companies by JUST Capital and CNBC, for the fourth consecutive year. This year, Illumina ranked #28, out of 100—up from #32 last year, and are ranked #2 in the pharmaceutical and biotech industry.

Awards, Ratings & Rankings

Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP
Illumina today announced its achievement of the highest score out of 72 companies in its industry in the S&P Global Corporate Sustainability Assessment, also known as the Dow Jones Sustainability Index (DJSI).

Responsible Business & Employee Engagement

Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration
Illumina CEO, Francis deSouza received the award for 3BL Media’s 2022 Responsible CEO of the Year: Innovation and ESG Integration.

Health & Healthcare

Illumina Announces Inaugural Illumina Genomics Forum With a Conversation With Former U.S. President Barack Obama
Illumina, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company's global event focused on advancing genomics-driven health.
Illumina logo

More from Illumina

  1. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  2. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  3. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  4. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  5. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...